Achieve Life Sciences Inc (ACHV)

$3.23 +0.09 (2.87%)
Market Cap 171.95M
Revenue (ttm) 0.00
Net Income (ttm) -54.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 504,800
Avg Vol 660,866
Day's Range N/A - N/A
Shares Out 53.23M
Stochastic %K 40%
Beta 1.96
Analysts Strong Sell
Price Target $14.86

Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washing...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 210 2217
Address:
22722 29th Dr. SE, Suite 100, Bothell, United States
Stockeye2
Stockeye2 Apr. 2 at 2:44 PM
$ACHV Bought more ✅
0 · Reply
DragonAlgo
DragonAlgo Apr. 2 at 7:18 AM
🐉 $ACHV CALL — DragonAlgo® Signal Contract: ACHV CALL Expiry: 2026-04-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.05 Stop: $0.04 TP1: $0.07 TP2: $0.09 TP3: $0.12 🔗 https://dragonalgo.com
1 · Reply
bobtheknob
bobtheknob Apr. 2 at 12:19 AM
$ACHV Going up to close the gap.
2 · Reply
MiguelitoLoveless
MiguelitoLoveless Apr. 1 at 2:51 PM
$ACHV You're so smart, I wish I was you
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 1 at 2:23 PM
$ACHV I mean I did tell u.. This is how we do it everyday.. No games.. I make money.. U make money 💰 💰
1 · Reply
Stockeye2
Stockeye2 Apr. 1 at 1:38 PM
$ACHV
0 · Reply
bobtheknob
bobtheknob Apr. 1 at 11:38 AM
$ACHV https://www.zerohedge.com/medical/not-just-cigarettes-vaping-likely-causes-cancer-major-study-finds
1 · Reply
markwall
markwall Apr. 1 at 6:02 AM
$ACHV
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 31 at 5:33 PM
$ACHV I told u when I added... We waited a few days but there u go.... Another winner with a $2.99 high still may go over $3.00... Beautiful!!
2 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 31 at 2:41 PM
$ACHV I'm green with profits.... Not $3.00 yet still think it's coming .... But a good bounce for us🥇🥇
0 · Reply
Latest News on ACHV
Achieve Life Sciences: The Recent Sell Off Skews The Outcomes

Apr 1, 2026, 11:39 AM EDT - 3 days ago

Achieve Life Sciences: The Recent Sell Off Skews The Outcomes

Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation

Mar 26, 2026, 1:28 PM EDT - 9 days ago

Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

Mar 26, 2026, 8:58 AM EDT - 10 days ago

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Mar 26, 2026, 8:30 AM EDT - 10 days ago

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript

Mar 24, 2026, 3:14 PM EDT - 11 days ago

Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript

Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 24, 2026, 2:23 PM EDT - 11 days ago

Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 24, 2026, 7:00 AM EDT - 12 days ago

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

Mar 17, 2026, 8:30 AM EDT - 19 days ago

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Mar 4, 2026, 8:00 AM EST - 4 weeks ago

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch

Feb 4, 2026, 8:57 PM EST - 2 months ago

Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy

Feb 4, 2026, 2:43 AM EST - 2 months ago

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Jan 30, 2026, 4:05 PM EST - 2 months ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Jan 12, 2026, 8:47 AM EST - 2 months ago

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Dec 17, 2025, 4:11 PM EST - 3 months ago

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 5 months ago

Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Nov 6, 2025, 7:00 AM EST - 5 months ago

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

Nov 3, 2025, 8:30 AM EST - 5 months ago

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

Oct 29, 2025, 8:30 AM EDT - 5 months ago

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Oct 20, 2025, 8:30 AM EDT - 5 months ago

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion

Oct 20, 2025, 7:15 AM EDT - 5 months ago

Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Oct 17, 2025, 7:30 AM EDT - 6 months ago

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Oct 2, 2025, 4:01 PM EDT - 6 months ago

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

Sep 22, 2025, 8:30 AM EDT - 6 months ago

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

Sep 18, 2025, 8:30 AM EDT - 7 months ago

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Sep 11, 2025, 5:01 PM EDT - 7 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

Sep 3, 2025, 8:30 AM EDT - 7 months ago

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Sep 2, 2025, 8:30 AM EDT - 7 months ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Aug 21, 2025, 2:11 PM EDT - 8 months ago

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 10:12 AM EDT - 8 months ago

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Aug 7, 2025, 7:30 AM EDT - 8 months ago

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

Jul 29, 2025, 8:30 AM EDT - 8 months ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

Jul 24, 2025, 8:30 AM EDT - 9 months ago

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

Jul 7, 2025, 1:55 PM EDT - 9 months ago

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

Jun 30, 2025, 7:52 PM EDT - 9 months ago

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Jun 26, 2025, 11:43 PM EDT - 10 months ago

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Jun 26, 2025, 4:03 PM EDT - 10 months ago

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Jun 26, 2025, 4:02 PM EDT - 10 months ago

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

OMC

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Jun 3, 2025, 6:28 PM EDT - 10 months ago

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

May 20, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

May 13, 2025, 12:16 PM EDT - 11 months ago

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

May 13, 2025, 7:30 AM EDT - 11 months ago

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

May 6, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Apr 21, 2025, 11:19 AM EDT - 1 year ago

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 2:52 PM EDT - 1 year ago

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

Mar 7, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

Mar 6, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

Feb 11, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

Feb 10, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

Stockeye2
Stockeye2 Apr. 2 at 2:44 PM
$ACHV Bought more ✅
0 · Reply
DragonAlgo
DragonAlgo Apr. 2 at 7:18 AM
🐉 $ACHV CALL — DragonAlgo® Signal Contract: ACHV CALL Expiry: 2026-04-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.05 Stop: $0.04 TP1: $0.07 TP2: $0.09 TP3: $0.12 🔗 https://dragonalgo.com
1 · Reply
bobtheknob
bobtheknob Apr. 2 at 12:19 AM
$ACHV Going up to close the gap.
2 · Reply
MiguelitoLoveless
MiguelitoLoveless Apr. 1 at 2:51 PM
$ACHV You're so smart, I wish I was you
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 1 at 2:23 PM
$ACHV I mean I did tell u.. This is how we do it everyday.. No games.. I make money.. U make money 💰 💰
1 · Reply
Stockeye2
Stockeye2 Apr. 1 at 1:38 PM
$ACHV
0 · Reply
bobtheknob
bobtheknob Apr. 1 at 11:38 AM
$ACHV https://www.zerohedge.com/medical/not-just-cigarettes-vaping-likely-causes-cancer-major-study-finds
1 · Reply
markwall
markwall Apr. 1 at 6:02 AM
$ACHV
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 31 at 5:33 PM
$ACHV I told u when I added... We waited a few days but there u go.... Another winner with a $2.99 high still may go over $3.00... Beautiful!!
2 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 31 at 2:41 PM
$ACHV I'm green with profits.... Not $3.00 yet still think it's coming .... But a good bounce for us🥇🥇
0 · Reply
BobBijawklah
BobBijawklah Mar. 31 at 12:13 PM
$ACHV potential buying oppurtunity in my opinion
0 · Reply
Gdellinger
Gdellinger Mar. 30 at 7:31 PM
$ACHV how low will it go when they do the offering? Already share price is below the last one on 6/25. Ugh.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 30 at 2:23 PM
$ACHV $3.00 Is coming in my opinion. And more... Not worried this dip was just more money 💰 💰
0 · Reply
DragonAlgo
DragonAlgo Mar. 30 at 2:20 PM
🐉 $ACHV CALL — DragonAlgo® Signal Contract: ACHV CALL Expiry: 2026-06-18 | Strike: $7.50 | Type: CALL Option Plan (premium): Entry: $0.08 Stop: $0.06 TP1: $0.10 TP2: $0.14 TP3: $0.19 🔗 https://dragonalgo.com
0 · Reply
V106GuY
V106GuY Mar. 27 at 10:21 PM
$ACHV for us long time investor's, we have been here many times and know earnings weeks always have a negative price effect . This is temporary as we know the end results even if we don't know the timing exactly. I Hold through and buy when it makes sense. These weeks are huge in the long term in my opinion but it is best to make your own.
2 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 27 at 6:50 PM
$ACHV Down on this one.. But not worried..... $3.00 And more imo... Watch this action🚨🚨
0 · Reply
Tomakak
Tomakak Mar. 27 at 5:41 PM
$ACHV bought 5k more to avg down
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 27 at 3:12 PM
$ACHV Adds! No reason this isn't $3.00 yet 🚨🚨
1 · Reply
Deeconomics
Deeconomics Mar. 27 at 3:06 PM
$ACHV For too long, the biotech industry has operated on the assumption that brilliant science alone justifies investment. It does not. The companies that are attracting capital today are those that can articulate not just what their molecule does, but why a specific development budget is commercially appropriate and offers competitive risk-adjusted returns. https://share.google/xF78Uu9lf20fkx6SP
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 27 at 12:50 AM
$ACHV Every day overnight swings.. U buy today sell tomorrow... We got this one today.. After an earnings drop but good news today this one is set to bounce big time with $3.00 next to Greek imo and the T-line at $3.46 very makeable🍒🍒🍒🍒
0 · Reply
NVRLCKY
NVRLCKY Mar. 26 at 7:08 PM
$ACHV
0 · Reply
the_Bull1
the_Bull1 Mar. 26 at 3:19 PM
$ACHV It seems that the manufacturing problem is not very serious. At this stage, even top pharmaceutical companies have received between 3 and 6 observations, with ACHV only 2. Even if they do not receive approval on June 20th, it is very likely that this will happen by the end of the year. The FDA has so far found nothing concerning about cytisycycline as a substance.
2 · Reply